SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C
http://www.w3.org/2000/01/rdf-schema#comment
"a significant survival benefit for p16-positive vaginal cancers compared with p16-negative cancers for stages I and II. No difference was observed in survival for MIB-1-positive tumors"
xsd:string
http://purl.uniprot.org/uniprot/#_245F7FC2E0AE0FB514B98334F4A00534176EB73DEBD84DD639B06D0A4C0A34E26CA382DF69475245119D84E55C4A88F0
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C
http://purl.uniprot.org/uniprot/Q86YT6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C
http://purl.uniprot.org/uniprot/#_Q86YT6-mappedCitation-25319982
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/96152D21E5D317FFA3E94DC64084A57518167EF092508D6EB62C3034A5747E58494C97EB78DEBEF8499D6DDE3302CF0C